A new screening service (Retasure, Digital Healthcare Inc.) is available to identify in primary-care and endocrinology practices those patients with diabetes who are at risk of developing diabetic retinopathy.
Poll: Do you believe biosimilars have the same efficacy as branded medications?
Opus Genetics receives FDA Clearance of IND application for OPGx-001 for treatment of retinal disease LCA5
Prevent Blindness marking second Geographic Atrophy Awareness Week on Dec. 5-11
